Doximity (DOCS)
NYSEHealth CareMedical - Healthcare Information ServicesSnapshot 2026-09-04
$26.35-2.77%
Close 2026-09-04 · 1-day change
NYSEHealth CareMedical - Healthcare Information ServicesSnapshot 2026-09-04
QuarterlyIQ Insights · DOCS
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 12 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $26 DOCS trades at 20× p/e, below its 20× p/e peer median. Our $28 fair value sits above the price. We hold it with medium confidence: quality doesn't explain valuation multiples in this sub-industry, so the peer comparison is a weak guide. Analysts target $18–$41. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $25.50 | — | — | Analyst | high |
| dcf fcfe | 12M | $73.10 | — | — | Hist. CAGR | high |
| dcf fcff | 12M | $74.53 | — | — | Hist. CAGR | high |
| graham number | 12M | $11.88 | — | — | TTM | high |
| Peer EV/EBITDA |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 25% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
$18.00 – $41.00 (median $25.50) · 18 analysts · as of 2026-08-13
No fragility gates fired. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Roughly priced in line with peers.
Richer than its own typical valuation.
Trailing four: 2026-Q1, 2026-Q2, 2026-Q3, 2027-Q1
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
| 12M |
| $10.76 |
| 10.1 |
| 0.92 |
| TTM |
| high |
| Peer P/FCF | 12M | $24.40 | 15.6 | 1.57 | TTM | high |
| Peer P/E | 12M | $26.68 | 20.4 | 1.31 | TTM | high |
| Peer P/S | 12M | $6.56 | 1.9 | 3.43 | TTM | high |
| PEG | 12M | $40.93 | 31.2 | 1.31 | TTM | high |
| residual income | 12M | $8.92 | — | — | TTM | high |
| Own P/E history | 12M | $20.11 | 15.4 | 1.31 | TTM | high |
| triangulated | 12M | $29.05 | 20.4 | 1.43 | Triangulated | high |
| Peer P/FCF | 3Y | $37.11 | 15.6 | 2.38 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $32.71 | 20.4 | 1.61 | Analyst | medium |
| Peer P/S | 3Y | $7.45 | 1.9 | 3.90 | guidance | medium |
| PEG | 3Y | $50.18 | 31.2 | 1.61 | Analyst | medium |
| Own P/E history | 3Y | $24.66 | 15.4 | 1.61 | Analyst | medium |
| Peer P/FCF | 5Y | $49.07 | 15.6 | 3.15 | Hist. CAGR(prov.) | high |
| Peer P/E | 5Y | $34.17 | 20.4 | 1.68 | Analyst | high |
| Peer P/S | 5Y | $7.78 | 1.9 | 4.07 | guidance | high |
| PEG | 5Y | $52.42 | 31.2 | 1.68 | Analyst | high |
| Own P/E history | 5Y | $25.76 | 15.4 | 1.68 | Analyst | high |